Sculptor Capital LP - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 51 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$3,564,361
+1.9%
352,9070.0%0.06%
+40.9%
Q3 2022$3,497,000
+1.2%
352,9070.0%0.04%
+18.9%
Q2 2022$3,455,000
-2.2%
352,907
-2.7%
0.04%
+37.0%
Q1 2022$3,532,000
+82.2%
362,618
+81.3%
0.03%
+68.8%
Q4 2021$1,938,000
+0.2%
199,9980.0%0.02%0.0%
Q3 2021$1,934,000
-0.7%
199,9980.0%0.02%
+14.3%
Q2 2021$1,948,000199,9980.01%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Exos Asset Management LLC 45,300$441,0000.23%
MMCAP International Inc. SPC 250,000$2,435,0000.12%
Atalaya Capital Management LP 40,000$386,0000.10%
Radcliffe Capital Management, L.P. 200,000$1,942,0000.06%
Arena Capital Advisors, LLC- CA 75,000$731,0000.06%
FIR TREE CAPITAL MANAGEMENT LP 150,000$1,449,0000.05%
Athanor Capital, LP 147,800$1,428,0000.05%
Woodline Partners LP 275,000$2,654,0000.05%
Ghisallo Capital Management LLC 125,000$1,208,0000.05%
SUVRETTA CAPITAL MANAGEMENT, LLC 300,000$2,922,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders